MedSource Labs in the Spotlight: A New York Times Feature on Nearshoring Success
We’re proud to share that our nearshoring efforts and partnership in Colombia have been featured in The New York Times. The article highlights our forward-thinking approach to global manufacturing and supply chain management.
This recognition in the press is a testament to our commitment to innovation, resilience, and improving lives in the communities where we operate.
“What matters most to us are the patients we serve and the security of the U.S. supply chain for critical medical devices.” Todd Fagley – CEO
Building Resilient Supply Chains
The article spotlights MedSource Labs’ strategic decision to invest in nearshoring—manufacturing in a location closer to the US. By expanding our production capabilities in Colombia, we’ve mitigated risks associated with supply chain disruptions, such as those brought on by geopolitical tensions and logistical challenges.
Todd Fagley, our CEO, spoke about the importance of this strategy in his statement to The New York Times: “What matters most to us are the patients we serve and the security of the U.S. supply chain for critical medical devices.”
Making a Positive Impact in Colombia
The article also highlights how our investment in Colombia is transforming lives. By partnering with Ronexmed, a joint venture led by Elias Daffach in Cartagena, MedSource Labs has helped create stable, well-paying jobs for local workers. These opportunities have uplifted families, improved living conditions, and fostered economic growth in the region.
We learn the inspiring story of Mariselis Pajaro, a factory employee whose stable income has allowed her family to build a brick home, purchase transportation, and find new security for the future.
Looking Ahead
While international trade remains complex, we remain committed to building partnerships that strengthen supply chains and empower communities. We’re honored by the recognition from The New York Times and the chance to share our story with a global audience.
Read the full article here
